Clinical Trial Update: [99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on [99mTc]Tc-DB8 imaging agent in primary breast cancer assessing ER-positive and ER-negative tumors; current status is enrolling …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• [99mTc]Tc-DB8

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Primary Breast Cancer | Phase 2 | Status: ENROLLING_BY_INVITATION